Phase I trial of ADR-002K for patients with ischemic cardiomyopathy who undergo coronary artery bypass surgery

Phase 1

• Conditions: Ischemic cardiomyopathy undergoing coronary artery bypass surgery; Coronary artery bypass, ischemic cardiomyopathy, adipose-derived mesenchymal stem cells; D017202

• Registration Number: JPRN-jRCT2053190103
• Lead Sponsor: SAWA Yoshiki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-01-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

1) Patients who are clinically diagnosed with ischemic cardiomyopathy and receive CABG
2) Patients with a left ventricular ejection fraction of 40% or less by cardiac ultrasonography within 4 weeks before obtaining consent
3) Others

Exclusion Criteria

1) Patients who have a combination of cardiovascular disease such as severe organic valvular disease or aortic aneurysm determined by investigator or co-investigator to affect clinical trial procedure
2) Patients whose participation in a clinical trial is considered inappropriate at the discretion of the investigator or co-investigator
3) Others

Study & Design

• Study Type: Interventional
• Study Design: Not specified